Supportive Care in Cancer

, Volume 19, Issue 3, pp 363–370 | Cite as

Patients’ views about causes and preferences for the management of cancer-related fatigue—a case for non-congruence with the physicians?

  • Christophe LuthyEmail author
  • Christine Cedraschi
  • Angela Pugliesi
  • Katie Di Silvestro
  • Beatrice Mugnier-Konrad
  • Elisabetta Rapiti
  • Anne-Francoise Allaz
Original Article



Cancer-related fatigue (CRF) is frequently overlooked. Adherence to treatment guidelines may be related to the patient’s views about illness. This study aimed at exploring patients’ views about CRF and determining whether they are congruent with best practice treatments.


Data were collected in 160 consecutive patients hospitalized in a supportive care setting. Biological, clinical, and psychological variables were assessed using validated questionnaires. Patients were also asked to complete the Brief Fatigue Inventory (BFI) and a questionnaire investigating their main symptoms and views about CRF and its management.


Patients were mainly men (60%); median age was 66 years. Various cancer diagnoses were represented; 17.5% had primary local diseases, 40% local recurrences, and 42.5% metastatic diseases. The majority of the patients experienced moderate or severe CRF (76.3%) on the BFI. Fatigue was the most frequently reported symptom (87.5%). Only anxiety, depression, and dimensions of quality of life were significantly related with CRF. Two thirds of the patients associated CRF with cancer-related morbidities. As for the best treatments, patients first stressed control of adverse effects. Over half of the patients were reluctant to report fatigue, mainly because they considered fatigue as an unavoidable side effect, but also because they feared a change towards less active/aggressive treatments.


Patients mostly consider that CRF must be tolerated. Guidelines emphasize activity enhancement strategies as beneficial. The patients’ preferences for rest rather than activity may be related to their high level of fatigue, which leads them to disregard activity as a possible treatment.


Fatigue Cancer-related fatigue Supportive care Patients’ views Treatment preferences Treatment guidelines 



The authors are grateful to Mrs. Wendy Pickering-Di Silvestro for language editing.

Conflict of interest



  1. 1.
    Mock V, Atkinson A, Barsevick A et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology 14:151–161PubMedGoogle Scholar
  2. 2.
    National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology – cancer-related fatigue, v.1.2009. Accessed 7 Dec 2009
  3. 3.
    Stone PC, Minton O (2008) Cancer-related fatigue. Eur J Cancer 44:1097–1104PubMedCrossRefGoogle Scholar
  4. 4.
    Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650PubMedCrossRefGoogle Scholar
  5. 5.
    Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM (2008) Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol 26:3886–3895PubMedCrossRefGoogle Scholar
  6. 6.
    Lesage P, Portenoy RK (2002) Management of fatigue in the cancer patient. Oncology 16:373–381PubMedGoogle Scholar
  7. 7.
    Flechtner H, Bottomley A (2003) Fatigue and quality of life: lessons from the real world. Oncologist 8:5–9PubMedCrossRefGoogle Scholar
  8. 8.
    Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801PubMedCrossRefGoogle Scholar
  9. 9.
    Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10:389–398PubMedCrossRefGoogle Scholar
  10. 10.
    Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl 1):4–10PubMedCrossRefGoogle Scholar
  11. 11.
    Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer fatigue forum. Ann Oncol 11:971–975PubMedCrossRefGoogle Scholar
  12. 12.
    Minton O, Stone P, Richardson A, Sharpe M, Hotopf M (2008) Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev 1:CD006704PubMedGoogle Scholar
  13. 13.
    Cramp F, Daniel J (2008) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2:CD006145PubMedGoogle Scholar
  14. 14.
    Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G (2009) Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev 1:CD006953PubMedGoogle Scholar
  15. 15.
    Donovan JL, Blake DR (1992) Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 34:507–513PubMedCrossRefGoogle Scholar
  16. 16.
    Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP (2005) Interventions for enhancing medication adherence. Cochrane Database Syst Rev, Issue 4Google Scholar
  17. 17.
    Blank T, Graves K, Sepucha K, Llewellyn-Thomas H (2006) Understanding treatment decision making: contexts, commonalities, complexities, and challenges. Ann Behav Med 32:211–217PubMedCrossRefGoogle Scholar
  18. 18.
    Piguet V, Cedraschi C, Dumont P, Desmeules J, Allaz AF, Dayer P (2007) Patients representations of antidepressants: a clue to nonadherence? Clin J Pain 23:669–675PubMedCrossRefGoogle Scholar
  19. 19.
    Mendoza TR, Wang XS, Cleeland CS (1999) The rapid assessment of fatigue severity in cancer patients. Cancer 85:1186–1196PubMedCrossRefGoogle Scholar
  20. 20.
    Whitehead L (2009) The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage 37:107–128PubMedCrossRefGoogle Scholar
  21. 21.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRefGoogle Scholar
  22. 22.
    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. J Clin Oncol 5:649–655CrossRefGoogle Scholar
  23. 23.
    Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRefGoogle Scholar
  24. 24.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRefGoogle Scholar
  25. 25.
    Razavi D, Delvaux N, Farvacques C, Robaye E (1989) Validation de la version française du HADS dans une population de patients cancéreux hospitalisés. Rev Psychol App 39:295–308Google Scholar
  26. 26.
    Passik SD, Kirsh KL, Donaghy K, Holtsclaw E, Theobald D, Cella D, Breitbart W, Fatigue Coalition (2002) Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manage 24:481–493PubMedCrossRefGoogle Scholar
  27. 27.
    Escalante CP (2003) Treatment of cancer-related fatigue: an update. Support Care Cancer 11:79–83PubMedGoogle Scholar
  28. 28.
    Echteld MA, Passchier J, Teunissen S, Claessen S, de Wit R, van der Rijt CC (2007) Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer 43:1030–1036PubMedCrossRefGoogle Scholar
  29. 29.
    Cella D (2006) Quality of life and clinical decisions in chemotherapy-induced anemia. Oncology 20:25–28PubMedGoogle Scholar
  30. 30.
    Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, Grendys E (2004) Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage 28:7–18PubMedCrossRefGoogle Scholar
  31. 31.
    Romito F, Montanaro R, Corvasce C, Di Bisceglie M, Mattioli V (2008) Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer 16:943–946PubMedCrossRefGoogle Scholar
  32. 32.
    Collins S, de Vogel-Voogt E, Visser A, van der Heide A (2008) Presence, communication and treatment of fatigue and pain complaints in incurable cancer patients. Patient Educ Couns 72:102–108PubMedCrossRefGoogle Scholar
  33. 33.
    Higginson IJ, Costantini M (2008) Dying with cancer, living well with advanced cancer. Eur J Cancer 44:1414–1424PubMedCrossRefGoogle Scholar
  34. 34.
    Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50:440–447PubMedCrossRefGoogle Scholar
  35. 35.
    Hay MC, Weisner TS, Subramanian S, Duan N, Niedzinski EJ, Kravitz RL (2008) Harnessing experience: exploring the gap between evidence-based medicine and clinical practice. J Eval Clin Pract 14:707–713PubMedCrossRefGoogle Scholar
  36. 36.
    Greenfield S, Kravitz R, Duan N, Kaplan SH (2007) Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment. Am J Med 120:S3–S9PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Christophe Luthy
    • 1
    Email author
  • Christine Cedraschi
    • 1
  • Angela Pugliesi
    • 2
  • Katie Di Silvestro
    • 1
  • Beatrice Mugnier-Konrad
    • 1
  • Elisabetta Rapiti
    • 3
  • Anne-Francoise Allaz
    • 1
  1. 1.Division of General Medical Rehabilitation, Department of Rehabilitation and GeriatricsGeneva University HospitalsGeneva 14Switzerland
  2. 2.Division of Oncology, Department of Internal MedicineGeneva University HospitalsGenevaSwitzerland
  3. 3.Cancer Registry, Institute of Social and Preventive MedicineGeneva University HospitalsGenevaSwitzerland

Personalised recommendations